Medindia

X

Mannatech Hosts Japan National Convention

Tuesday, October 23, 2007 General News J E 4
Advertisement
COPPELL, Texas, Oct. 22 Mannatech, Incorporated(Nasdaq: MTEX), a leading developer and provider of dietary supplements andskin care solutions, hosted its annual Japan National Convention at Tokyo'sRyogoku Kokugikan October 12 - 13, 2007, with 1,500 independent salesAssociates and Members from Japan in attendance.

"We are excited to introduce our Japan market to PhytoMatrix, Mannatech'smost advanced multivitamin/mineral/phytochemical product with no synthetic orchemical ingredients," said Terry Persinger, Mannatech's president and chiefexecutive officer. "To the best of our knowledge, PhytoMatrix is the nutritionindustry's first supplement containing completely standardized levels of allnatural vitamin complexes, 100 percent plant sourced minerals, andstandardized phytochemicals."

Mannatech also introduced a premier business development tool, the One onOne Visual Presentation Tool, which will help Associates and Members introduceMannatech's products, science and business opportunities during salespresentations. The Presentation Tool has been used in other Mannatech marketswith great success.

Team Mannatech, a diverse group of athletes and sports figures from aroundthe world who attest to the benefits of a healthy lifestyle and serve as rolemodels to people of all ages, also introduced the newest team members fromJapan.

Persinger added, "Our continued success in the Japanese market is atestament to our quality products and dedicated independent sales Associates."

Japan was among the first countries to be opened by Mannatech and now itsproducts are sold in 10 countries, including the United States, Canada,Australia, the United Kingdom, Germany, New Zealand, the Republic of Korea,Taiwan and Denmark.

About Mannatech

Mannatech, Incorporated is a global wellness solutions provider ofinnovative, high-quality, proprietary nutritional supplements, topical andskin care products, and weight management products sold through independentassociates and members located in the United States and the internationalmarkets of Canada, Australia, the United Kingdom, Japan, New Zealand, theRepublic of Korea, Taiwan, Denmark, and Germany.

Please Note: This release contains "forward-looking statements" within themeaning of Section 27A of the Securities Act of 1933, as amended, Section 21Eof the Securities Exchange Act of 1934, as amended, and the Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements generally canbe identified by use of phrases or terminology such as "intend" or othersimilar words or the negative of such terminology. Similarly, descriptions ofMannatech's objectives, strategies, plans, goals or targets contained hereinare also considered forward-looking statements. Mannatech believes thisrelease should be read in conjunction with all of its filings with the UnitedStates Securities and Exchange Commission and cautions its readers that theseforward-looking statements are subject to certain events, risks,uncertainties, and other factors. Some of these factors include, among others,Mannatech's inability to attract and retain associates and members, increasesin competition, litigation, regulatory changes, and its planned growth intonew international markets. Although Mannatech believes that the expectations,statements, and assumptions reflected in these forward-looking statements arereasonable, it cautions readers to always consider all of the risk factors andany other cautionary statements carefully in evaluating each forward-lookingstatement in this release, as well as those set forth in its latest AnnualReport on Form 10-K and Quarterly Report on Form 10-Q, and other filings filedwith the United States Securities and Exchange Commission, including itscurrent reports on Form 8-K. All of the forward-looking statements containedherein speak only as of the date of this release.Contact Infor
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
SPO Medical Announces Major Sales Milestone
S
Cutting Edge CyberKnife Cancer Treatment Center to...